Qiagen N.V. (QGEN)

Healthcare · Diagnostics Research · NYSE

Qiagen N.V. (QGEN) is a Healthcare company in the Diagnostics Research industry. It has a market capitalization of $8.72B, a trailing price-to-earnings ratio of 17.5 and a free-cash-flow yield of 5.1%. Over the most recent reported fiscal year, revenue grew 5.7% and free cash flow per share fell 11.1%.

Market cap	$8.72B
Trailing P/E	17.5
FCF yield	5.1%
Revenue growth (YoY)	+5.7%
EPS growth (YoY)	+4.7%
FCF/share growth (YoY)	-11.1%
Exchange	NYSE
Sector	Healthcare
Industry	Diagnostics Research

Explore live QGEN data on Nama Insights →

Recent Congressional trades

Qiagen N.V. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Alan S. Lowenthal	House	Sell	$737.20	Nov 1, 2019
Alan S. Lowenthal	House	Sell	$1,001 - $15,000	Nov 1, 2019
Alan S. Lowenthal	House	Sell	$15,001	Nov 1, 2019
Alan S. Lowenthal	House	Buy	$135.55	Sep 21, 2019
Alan S. Lowenthal	House	Buy	$1,001 - $15,000	Sep 21, 2019
Alan S. Lowenthal	House	Buy	$1,001 - $15,000	Sep 21, 2019
Donna Shalala	House	Sell	$1,001 - $15,000	Jan 31, 2019